We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

The Dolutegravir Antiretroviral Mono-Therapy for HIV Trial (DOMONO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02401828
Recruitment Status : Completed
First Posted : March 30, 2015
Last Update Posted : January 28, 2020
Information provided by (Responsible Party):
Bart Rijnders, Erasmus Medical Center